EDIT Message Board Post 9191012 | Editas Medicine Inc.
home / stock / edit / edit message board
Lanemyers
(investorshub)
Posted on: Jan/07/2021 15:25:05
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160752357
Genome Stocks-Gene Editing.
News, Short Squeeze, Breakout and More Instantly...
-
All patients treated in the RUBY trial are free of vaso-occlusive events post- renizgamglogene autogedtemcel (reni-cel) infusion Patients had early normalization of total hemoglobin with a mean within the normal range at >14 g/dL and rapid and sustained improvements in fetal ...
-
All patients treated in the EdiTHAL trial maintained hemoglobin levels above the transfusion threshold and are transfusion-free post- renizgamglogene autogedtemcel (reni-cel) infusion Reni-cel was well-tolerated and demonstrated a safety profile consistent with myeloablative con...